Investigational oral drug molnupiravir appears useful for COVID-19
A single pill of the investigational drug molnupiravir taken twice a day for 5 days eliminated SARS-CoV-2 from the nasopharynx of 49 participants. Read More: https://www.medscape.com/viewarticle/947061